These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35803470)

  • 1. Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children.
    Ricciardi A; Zelini P; Cassaniti I; Avanzini MA; Colaneri M; De Silvestri A; Baldanti F; Bruno R
    Int J Infect Dis; 2022 Sep; 122():905-909. PubMed ID: 35803470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing Activity and SARS-CoV-2 Vaccine mRNA Persistence in Serum and Breastmilk After BNT162b2 Vaccination in Lactating Women.
    Yeo KT; Chia WN; Tan CW; Ong C; Yeo JG; Zhang J; Poh SL; Lim AJM; Sim KHZ; Sutamam N; Chua CJH; Albani S; Wang LF; Chua MC
    Front Immunol; 2021; 12():783975. PubMed ID: 35087517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participants.
    Longueira Y; Ojeda DS; Battistelli RBA; Sanchez L; Oviedo Rouco S; Albano D; Guevara E; Valls V; Pando MA; Gamarnik AV
    Front Immunol; 2022; 13():909995. PubMed ID: 36263055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.
    Selma-Royo M; Bäuerl C; Mena-Tudela D; Aguilar-Camprubí L; Pérez-Cano FJ; Parra-Llorca A; Lerin C; Martínez-Costa C; Collado MC
    Genome Med; 2022 Apr; 14(1):42. PubMed ID: 35449030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women.
    Lechosa-Muñiz C; Paz-Zulueta M; Irure-Ventura J; Mendez-Legaza JM; Cuesta González R; Gómez-Acebo I; López-Hoyos M; Llorca J; Cabero-Pérez MJ
    Int Breastfeed J; 2023 Jan; 18(1):3. PubMed ID: 36627706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads.
    Golan Y; Prahl M; Cassidy AG; Gay C; Wu AHB; Jigmeddagva U; Lin CY; Gonzalez VJ; Basilio E; Chidboy MA; Warrier L; Buarpung S; Li L; Murtha AP; Asiodu IV; Ahituv N; Flaherman VJ; Gaw SL
    Front Immunol; 2021; 12():777103. PubMed ID: 34804068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod.
    Capuano R; Bisecco A; Conte M; Donnarumma G; Altieri M; Grimaldi E; Franci G; Chianese A; Galdiero M; Coppola N; Tedeschi G; Gallo A
    Mult Scler Relat Disord; 2022 Apr; 60():103724. PubMed ID: 35272145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 mRNA vaccine and antibody response in lactating women: a prospective cohort study.
    Charepe N; Gonçalves J; Juliano AM; Lopes DG; Canhão H; Soares H; Serrano EF
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):632. PubMed ID: 34535094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Acute Respiratory Syndrome Coronavirus 2 Infection Versus Vaccination in Pregnancy: Implications for Maternal and Infant Immunity.
    Conti MG; Terreri S; Terrin G; Natale F; Pietrasanta C; Salvatori G; Brunelli R; Midulla F; Papaevangelou V; Carsetti R; Angelidou A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S37-S45. PubMed ID: 35535796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Levels of SARS-CoV-2 Specific Antibodies in Human Milk Following Vaccination.
    Juncker HG; Mulleners SJ; van Gils MJ; de Groot CJM; Pajkrt D; Korosi A; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):477-484. PubMed ID: 34176363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults.
    Rastawicki W; Juszczyk G; Gierczyński R; Zasada AA
    J Clin Virol; 2022 Jul; 152():105193. PubMed ID: 35660747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of humoral and cell-mediated immune response after SARS-CoV-2 mRNA vaccine administration.
    Mihaylova A; Lesichkova S; Baleva M; Nikolova-Vlahova M; Kundurzhiev T; Kolevski A; Naumova E
    J Med Virol; 2023 Jan; 95(1):e28360. PubMed ID: 36448089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained and Boosted Antibody Responses in Breast Milk After Maternal SARS-CoV-2 Vaccination.
    Ware J; McElhinney K; Latham T; Lane A; Dienger-Stambaugh K; Hildeman D; Spearman P; Ware RE
    Breastfeed Med; 2023 Aug; 18(8):612-620. PubMed ID: 37615566
    [No Abstract]   [Full Text] [Related]  

  • 15. Maternal Immunization During the Second Trimester with BNT162b2 mRNA Vaccine Induces a Robust IgA Response in Human Milk: A Prospective Cohort Study.
    Kigel A; Vanetik S; Mangel L; Friedman G; Nozik C; Terracina C; Taussig D; Dror Y; Samra H; Mandel D; Lubetzky R; Wine Y
    Am J Clin Nutr; 2023 Sep; 118(3):572-578. PubMed ID: 37479184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of SARS-CoV-2-Specific IgG and IgA in Serum and Milk with Different SARS-CoV-2 Vaccines in Breastfeeding Women: A Cross-Sectional Study in Northern Spain.
    Lechosa-Muñiz C; Paz-Zulueta M; Mendez-Legaza JM; Irure-Ventura J; Cuesta González R; Calvo Montes J; López-Hoyos M; Llorca J; Cabero-Pérez MJ
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination.
    Young BE; Seppo AE; Diaz N; Rosen-Carole C; Nowak-Wegrzyn A; Cruz Vasquez JM; Ferri-Huerta R; Nguyen-Contant P; Fitzgerald T; Sangster MY; Topham DJ; Järvinen KM
    JAMA Pediatr; 2022 Feb; 176(2):159-168. PubMed ID: 34757387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory IgA and T cells targeting SARS-CoV-2 spike protein are transferred to the breastmilk upon mRNA vaccination.
    Gonçalves J; Juliano AM; Charepe N; Alenquer M; Athayde D; Ferreira F; Archer M; Amorim MJ; Serrano F; Soares H
    Cell Rep Med; 2021 Dec; 2(12):100468. PubMed ID: 34873588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion.
    Pieri M; Maniori MA; Shahabian L; Kanaan E; Paphiti-Demetriou I; Pipis S; Felekkis K; Nicolaidou V; Papaneophytou C
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014873
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.